Awarded

BH - NonClinical Pharmacy Car-T

Descriptions

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells.

The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products

At the time of writing it is only offered at 8 sites across the UK.

The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order.

The price paid to the supplier with be capped at NICE / NHS England approved list prices.

Timeline

Published Date :

26th Nov 2025 2 days ago

Deadline :

N/A

Tender Awarded :

1 Supplier

Awarded date :

N/A

Contract Start :

N/A

Contract End :

N/A

Keywords

medical equipment

pharmaceutical products

personal care items

healthcare supplies

medical devices

hospital pharmacy

clinical pharmacy

inpatient medication dispensing

sterile compound preparation

pharmacological management

medication safety services

pharmaceutical stock management

IV admixture

formulary services

hospital drug distribution

Tender Lot Details

2 Tender Lots

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Procedure :

N/A

Suitable for SME :

N/A

Nationwide :

No

Assign to :

Tender Progress :

0%

Details

Notice Type :

Tender

Tender Identifier :

IT-378-246-T: 2024 - 001

Tenderbase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement contact

Name :

Tina Smith

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors